GSK NYSE · Healthcare · FY 2025-12-31

GSK plc

Back to NYSE
0.016.533.049.566.0ABVnot valid for this companyEPVfair 22.72buy ≤ 12.50EBVnot valid for this companyDBVfair 61.08buy ≤ 27.48price 38.81 GBP
0.022.043.965.987.9ABVnot valid for this companyEPVfair 30.26buy ≤ 16.64EBVnot valid for this companyDBVfair 81.35buy ≤ 36.61price 51.69 USD
ABV EPV EBV DBV fair value / share buy at or below (margin of safety applied) margin-of-safety band current price values in GBPUSD
Verdict
Wait
Buy zone
Fair–Wait
Archetype
Asset-Light Compounder
Confidence
●●○ Medium · 2/4
Price
38.80751.690 GBPUSD *
Market cap
155.71B207.41B GBPUSD *
P / B
9.51
P / E
13.98
EPS
2.7763.698
DPS / yield
1.3451.792 (3.5%)
NAV / share
-1.946-2.593
Graham number
15.96621.267
Z'' score
1.40
Piotroski F
9 / 9
Beneish M
-2.53
ROIC vs WACC
22.2% vs 6.1%

* Listed in USD — the pipeline states price and all valuations in the filing currency GBP (fx 0.75 GBP/USD).

See the full orchestrator pipeline — solvency gate, lens cascade, reconciliation, archetype, decision, and confidence.

Subscribe to unlock this and every other tab for every company.

See the full ABV lens breakdown — gates, steps, and verdict.

Subscribe to unlock this and every other tab for every company.

See the full EPV lens breakdown — gates, steps, and verdict.

Subscribe to unlock this and every other tab for every company.

See the full EBV lens breakdown — gates, steps, and verdict.

Subscribe to unlock this and every other tab for every company.

See the full DBV lens breakdown — gates, steps, and verdict.

Subscribe to unlock this and every other tab for every company.